Showing results (51-60 of 144) with videos related to
Sort By:
Pageof 15
Clinical and Experimental Pharmacology & Physiology|April 1, 1993
Effects of aldose reductase inhibition with epalrestat on diabetes-induced changes in rat isolated atriaR J Booth, W C HodgsonEuropean Journal of Immunology|May 1, 1979
The proliferative capacity of human T lymphocyte subpopulations in a continuous culture systemG T Pang, R J BoothJournal of Immunology (Baltimore, Md. : 1950)|September 1, 1984
Interleukin 1 induces proliferation in two distinct B cell subpopulations responsive to two different murine B cell growth factorsR J Booth, J D WatsonOncology Research|January 1, 1992
Resistance mechanisms to topoisomerase poisons: the application of cell culture methodsB C Baguley, G J Finlay, L M ChingOncology Research|January 1, 1997
Differential actions of aclarubicin and doxorubicin: the role of topoisomerase ID J Bridewell, G J Finlay, B C BaguleyCancer Research|December 15, 1987
Abnormal insulin-receptor down regulation and dissociation of down regulation from insulin biological action in cultured human tumor cellsK G Mountjoy, G J Finlay, I M HoldawayEuropean Journal of Cancer & Clinical Oncology|June 1, 1986
Comparison of in vitro activity of cytotoxic drugs towards human carcinoma and leukaemia cell linesG J Finlay, W R Wilson, B C BaguleyOncology Research|February 26, 2000
Inhibition of the action of the topoisomerase II poison amsacrine by simple aniline derivatives: evidence for drug-protein interactionsG J Finlay, G J Atwell, B C BaguleyCancer Research|October 1, 1983
Insulin receptor regulation in cultured human tumor cellsK G Mountjoy, I M Holdaway, G J FinlayEuropean Journal of Cancer & Clinical Oncology|December 1, 1989
Chemoprotection by 9-aminoacridine derivatives against the cytotoxicity of topoisomerase II-directed drugsG J Finlay, W R Wilson, B C BaguleyPageof 15